(InSilico Medicine, Inc.) Alex Zhavoronkov, Founder and CEO of Insilico Medicine presents 'The Power of GANs and RL in pharma R&D: from Experimentally-Validated End-to-End Drug Discovery Pipelines to Generation of Synthetic Patients' at The AI Applications in Biopharma Summit 2018 in Boston.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2SeNugy
No comments:
Post a Comment